TPG, a global alternative asset manager, agreed to acquire a majority stake in DOC Generici, a manufacturer of generic pharmaceuticals, from ICG, an asset management, and Merieux Equity Partners, a private equity firm. Financial terms were not disclosed. “As the Italian generics market continues to grow, DOC Generici has established itself as a trusted partner of choice for patients, physicians, and pharmacists with a focus on high quality products and lowering the cost of drugs to patients. We look forward to partnering with Riccardo and the management team to grow their leadership in the market through continued organic and inorganic investments in the business. We are also excited to invest in the Italian market, which we believe presents attractive opportunities in the years to come,” Karthic Jayaraman, TPG Capital Partner.